Pediatric Neurology Disorders News


Oct 30, 2018
Sodium oxybate approved for treatment of cataplexy or EDS in pediatric narcolepsy patients
This approval of Xyrem by the FDA marks the first medicine approved to treat cataplexy or excessive daytime sleepiness (EDS) in children and adolescents with narcolepsy ages seven and older.
Oct 29, 2018
Prenatal phthalate exposure significantly associated with elevated rate of language delay in childre
Elevated rate of language delay in children at 30 months old who were born to mothers exposed to phthalates.
Aug 21, 2018
Children with brain tumors who undergo radiation less likely to recall recent events
"The surprise, and the up side, is that episodic memories from before the children's treatment were spared," Baylor researcher says.
Jan 29, 2018
Pyridostigmine treatment reverses pediatric complications of botulinum toxin therapy
Report suggests a drug for myasthenia gravis can also quickly and safely reverse complications from botulinum toxin therapy in pediatric patients.
Oct 30, 2017
Umbilical cord blood improves motor skills in some children with cerebral palsy
Clinical trial shows improved motor function in children infused with own cells.
Aug 03, 2017
Most newborns with epilepsy benefit from genetic testing
Research published in Neurology analyzed data from the Neonatal Seizure Registry that includes enrollees from 7 children's hospitals. It found that most newborns with epilepsy would benefit from genetic testing because the majority of cases are linked to identifiable genetic causes.
Feb 09, 2017
Gene variant identified for Kawasaki disease susceptibility
Researchers have conducted novel whole genome sequencing of a family in which 2 of 4 children were affected by Kawasaki disease, and have identified plausible gene variants that predispose some children to developing the disease. The findings are published in the PLOS ONE.
Dec 13, 2016
Research identifies a molecular basis for common congenital brain defect
Scientists have discovered a molecular cause of hydrocephalus. Because the same molecule is also implicated in Down syndrome, the finding, published today in the Journal of Neuroscience, may explain the 10-fold increased risk of hydrocephalus in infants born with Down syndrome.